Manufacturing facility
Rubicon Research Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- J 4/2, ADDITIONAL MIDC, Satara, Maharashtra 415004, India (IND)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3012953979 · DUNS 737796233
Drugs this plant is listed as making
14 distinct drugs across 16 products name this site in their FDA label.
- AcyclovirAdvagen Pharma Limited
- AripiprazoleAdvagen Pharma Ltd
- BaclofenAdvagen Pharma Ltd.,
- Cetirizine hydrochlorideAdvagen Pharma Ltd.,
- chlorpromazine hydrochlorideAdvagen Pharma Ltd
- gabapentinAdvagen Pharma Ltd
- HaloperidolAdvagen Pharma Ltd
- Lidocaine hydrochloridein shortageAdvagen Pharma Ltd
- LithiumAdvagen Pharma Ltd
- Metoprolol TartrateValidus Pharmaceuticals Llc
- Nortriptyline HydrochlorideAdvagen Pharma Ltd
- OxcarbazepineAdvagen Pharma Ltd
- Potassium ChlorideAdvagen Pharma Limited
- Valsartan oralAdvagen Pharma Ltd
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.